USDA Takes Charge Amid Avian Flu Concerns
Uncertainty at CDC and NIH
While there is ongoing uncertainty surrounding the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH), the US Department of Agriculture (USDA) remains committed to addressing avian flu issues. Recent weeks have seen heightened concerns regarding the bird flu, especially as the US government has paused clinical research, epidemiology, and pandemic preparedness efforts.
USDA’s Continued Monitoring
The USDA is primarily focused on monitoring bird flu within commercial poultry operations and dairy herds. Despite the challenges faced by other health agencies, the USDA will continue its surveillance of the avian flu epidemic. In the long term, it is crucial to restore funding for the infection and immunity programs at the CDC and NIH to enhance North American biosecurity. Until such funding is reinstated, the USDA may act as a temporary safeguard against the outbreak.
Funding Competition for Avian Influenza Research
In a communication released this week, the USDA announced a funding competition aimed at bolstering research efforts to combat the highly pathogenic strains of avian influenza currently affecting poultry farms across the United States. This initiative will prioritize projects related to prevention, therapeutics, and vaccine development.
Investment and Priorities
With a commitment of $100 million, the USDA will focus on several key areas, including:
– Development of novel therapeutics and improved diagnostics to tackle HPAI in poultry.
– Research aimed at understanding risk pathways of avian influenza to inform better biosecurity and response strategies.
– Creation of new vaccines designed to protect poultry from HPAI while enhancing biosecurity measures.
The USDA has set a deadline of May 19, 2025, for project submissions. More details about this funding opportunity can be accessed at grants.gov with the reference number mUSDA-APHIS-10025-VSSP0000-25-0015.